Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Pathumwan, Bangkok, 10330, Thailand.
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Phli, Samut Prakarn, 10540, Thailand.
Sci Rep. 2022 Dec 1;12(1):20789. doi: 10.1038/s41598-022-24935-7.
Centell-S is a water-soluble extract of Centella asiatica containing more than 80% w/w triterpenoid glycosides. Madecassoside and asiaticoside are two major components of the extract and can be converted into active metabolites, triterpenic acids in large mammal species. In this study, the pharmacokinetic profiles and metabolomic changes generated by the bioactive triterpenoids of Centell-S alone, and in combination with the bioenhancers piperine and curcumin, were investigated in beagle dogs. The test substances were orally administered over multiple doses for 7 consecutive days. At day 1 and 7 after receiving the test compounds, the level of major bioactive triterpenoids and related metabolites were measured using triple quadrupole and high-resolution accurate mass orbitrap models of LCMS to determine pharmacokinetic and metabolomic profiles, respectively. Centell-S was well tolerated, alone and in all combination groups. The combination of Centell-S and piperine significantly increased (p < 0.05) the systemic exposure of madecassoside on day 1 and asiatic acid on day 7, by approximately 1.5 to 3.0-fold of C and AUC values as compared to the Centell-S alone, while the addition of curcumin did not provide a significant improvement. Several metabolomic changes were observed from pre-dose to 4 h post-dose, with some biomarkers of neurodegenerative diseases including L-glutamine, lysophosphatidylcholine (17:0), taurochenodeoxycholic acid, uric acid, stearic acid, palmitic acid, and lactic acid showing good correlation with the systemic exposure of the bioactive triterpenoids (asiatic acid). Thus, the combining of piperine to Centell-S exhibits the improvement of bioactive triterpenoids which are related to the biomarkers of neurodegenerative diseases. These promising results might be useful for the development of this standardised extract to become a more effective phytomedicine for neurodegenerative diseases.
喜疗妥是积雪草的水溶性提取物,含有超过 80%w/w 的三萜糖苷。积雪草苷和羟基积雪草苷是提取物的两种主要成分,可在大型哺乳动物物种中转化为活性代谢物,三萜酸。在这项研究中,单独使用喜疗妥的生物活性三萜和与生物增强剂胡椒碱和姜黄素联合使用的生物活性三萜的药代动力学特征和代谢组学变化在比格犬中进行了研究。试验物质连续 7 天每天口服多次给药。在接受试验化合物后的第 1 天和第 7 天,使用 LCMS 的三重四极杆和高分辨率精确质量轨道阱模型测量主要生物活性三萜及其相关代谢物的水平,分别确定药代动力学和代谢组学特征。单独使用和所有联合组均能良好耐受喜疗妥。喜疗妥与胡椒碱联合使用可显著增加(p<0.05)第 1 天的积雪草苷和第 7 天的积雪草酸的全身暴露,与单独使用喜疗妥相比,C 和 AUC 值增加约 1.5 至 3.0 倍,而添加姜黄素则不能显著改善。从预剂量到 4 小时后剂量观察到几种代谢组学变化,一些神经退行性疾病的生物标志物,包括 L-谷氨酰胺、溶血磷脂酰胆碱(17:0)、牛磺鹅去氧胆酸、尿酸、硬脂酸、棕榈酸和乳酸,与生物活性三萜(积雪草酸)的全身暴露具有良好的相关性。因此,胡椒碱与喜疗妥联合使用可改善与神经退行性疾病相关的生物活性三萜。这些有希望的结果可能有助于开发这种标准化提取物,使其成为治疗神经退行性疾病更有效的植物药。